@article{Danwilai_Samutpeth_Pongsura_Jitpewngarm_Manoi_2021, title={Comparison of Efficacy between Short Hydration and Continuous Hydration for Prevention of Cisplatin Induced Nephrotoxicity}, volume={36}, url={https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/252557}, abstractNote={<p><strong><u>Background and Objective</u></strong><strong><u>:</u></strong> Cisplatin is antineoplastic drug that has been used in the treatment of several type of solid tumor and hematologic malignancies. Nephrotoxicity is one of the major and most serious toxicities caused by cisplatin. Hydration is used very commonly and while effective but several strategies able to prevent nephrotoxicity. This study was to comparison efficacy of short and continuous hydration for prevention of cisplatin induced nephrotoxicity (CIN).</p> <p><strong><u>Methods:</u></strong> The retrospective study collected data from medical records and electronic databases between 1 January 2011 and 31 December 2018. Inclusion criteria was solid tumors type of patients with age ≥ 20 years old received single cisplatin or combination regimen as inpatients setting, divided into 2 groups, short hydration group (1 L 0.9%NaCl intravenous rate ≥ 500 ml/hr) and continuous hydration group (1 L 0.9%NaCl intravenous rate < 200 ml/hr) for prevention of CIN and performance status (ECOG) 0-2. No data for evaluation of efficacy and serum creatinine > 1.5 mg/dl prior treatment were excluded. Primary outcome was the incidence of CIN ≥ grade 3 after received cisplatin at any cycles. Grading of nephrotoxicity classified by common terminology criteria for adverse events (CTCAE) 5.0.</p> <p><strong><u>Results:</u></strong> A total of 81 patients were enrolled. Forty eight patients in short hydration group; median cisplatin dose was 69.33±16.03 mg/m<sup>2</sup>. Thirtythree patients in the continuous hydration group; median cisplatin dose was 73.39±14.72 mg/m<sup>2</sup>. No incidence of CIN ≥ grade 3 at any cycles reported after received cisplatin. The different of incidence of CIN at any cycles any grade between short hydration group and continuous hydration group did not reach statistical significance  [15 patients (31.2%) vs 16 patients (48.5); p=0.12]. The incidence of CIN at cycle 1 any grade different between 2 groups did not reach statistical significance [6 patients (12.5%) in short hydration group and 4 patients (12.1%) in continuous hydration group; p=0.95].</p> <p><strong><u>Conclusion:</u> </strong>This study showed benefit of short and continuous hydration group were similar for prevention of cisplatin induced nephrotoxicity.</p>}, number={5}, journal={Srinagarind Medical Journal}, author={Danwilai, Kwanjit and Samutpeth, Pongpipat and Pongsura, Saharat and Jitpewngarm, Wittawat and Manoi, Apichai}, year={2021}, month={Oct.}, pages={562–568} }